全文获取类型
收费全文 | 2582篇 |
免费 | 189篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 130篇 |
妇产科学 | 70篇 |
基础医学 | 289篇 |
口腔科学 | 44篇 |
临床医学 | 231篇 |
内科学 | 615篇 |
皮肤病学 | 141篇 |
神经病学 | 256篇 |
特种医学 | 191篇 |
外科学 | 272篇 |
综合类 | 24篇 |
一般理论 | 1篇 |
预防医学 | 127篇 |
眼科学 | 68篇 |
药学 | 137篇 |
中国医学 | 1篇 |
肿瘤学 | 161篇 |
出版年
2023年 | 11篇 |
2022年 | 26篇 |
2021年 | 62篇 |
2020年 | 37篇 |
2019年 | 80篇 |
2018年 | 82篇 |
2017年 | 47篇 |
2016年 | 58篇 |
2015年 | 51篇 |
2014年 | 73篇 |
2013年 | 83篇 |
2012年 | 103篇 |
2011年 | 118篇 |
2010年 | 89篇 |
2009年 | 78篇 |
2008年 | 124篇 |
2007年 | 96篇 |
2006年 | 119篇 |
2005年 | 101篇 |
2004年 | 85篇 |
2003年 | 81篇 |
2002年 | 80篇 |
2001年 | 59篇 |
2000年 | 97篇 |
1999年 | 57篇 |
1998年 | 56篇 |
1997年 | 68篇 |
1996年 | 64篇 |
1995年 | 54篇 |
1994年 | 28篇 |
1993年 | 35篇 |
1992年 | 40篇 |
1991年 | 43篇 |
1990年 | 27篇 |
1989年 | 46篇 |
1988年 | 45篇 |
1987年 | 40篇 |
1986年 | 48篇 |
1985年 | 32篇 |
1984年 | 24篇 |
1983年 | 15篇 |
1982年 | 14篇 |
1981年 | 22篇 |
1980年 | 18篇 |
1979年 | 14篇 |
1978年 | 16篇 |
1977年 | 14篇 |
1976年 | 14篇 |
1975年 | 22篇 |
1973年 | 17篇 |
排序方式: 共有2774条查询结果,搜索用时 15 毫秒
61.
62.
63.
64.
Membrane-associated sickle hemoglobin: a major determinant of sickle erythrocyte rigidity 总被引:1,自引:0,他引:1
Micropipette aspiration tests on single erythrocytes have previously shown that the static rigidity (membrane shear modulus) of oxygenated sickle cells increased with increasing hemoglobin concentration, whereas the rigidity of normal cells was independent of hemoglobin concentration. Moreover, it was observed that after mechanical extension, sickle cells exhibited persistent deformation more frequently and to a greater extent than normal cells. To ascertain if differences in association of normal and sickle hemoglobin with the membrane could account for these observations, we measured rheologic properties of normal membranes reconstituted with sickle hemoglobin and sickle membranes reconstituted with normal hemoglobin. The static rigidity of normal ghosts reloaded with sickle hemoglobin was higher than those of either normal ghosts reloaded with normal hemoglobin or native normal cells. On the other hand, the increased rigidity of native sickle cells decreased to near-normal values following reconstitution with normal hemoglobin. Furthermore, we observed that normal ghosts reconstituted with sickle hemoglobin exhibited persistent bumps after mechanical extension, but no bumps formed on normal ghosts reconstituted with normal hemoglobin. Moreover residual bumps were not produced on sickle cells reloaded with normal hemoglobin. Since mechanical characteristics peculiar to sickle cells could be induced in normal cells by incorporation of sickle hemoglobin, and since normal characteristics could be restored to sickle cells by incorporation of normal hemoglobin, we suggest that the interaction of sickle hemoglobin with the cell membrane is responsible for augmented static rigidity of oxygenated sickle erythrocytes. 相似文献
65.
Crosslinking the CD27 antigen on T cells provides a costimulatory signal that, in concert with T-cell receptor crosslinking, can induce T- cell proliferation and cellular immune activation. We find that chronic lymphocytic leukemia (CLL) B cells from most patients coexpress both membrane-bound and soluble CD27, along with its newly identified ligand, CD70. The expression of soluble CD27 may preclude leukemic B cells from stimulating T cells via CD70, thereby potentially impairing their ability to function as effective antigen-presenting cells. We find that leukemic B-cell expression of soluble and membrane-bound CD27 can be downmodulated through a CD40-dependent signal. This signal also induces enhanced expression of CD70 on both normal and leukemic B cells. We find that tumor necrosis factor (TNF)-alpha, or the Th1 cytokine interferon (IFN)-gamma, also can induce downmodulation of CD27, whereas Th2-associated cytokines interleukin-4 (IL-4) or IL-10 can enhance leukemic B-cell expression of this accessory molecule. The modulation of CD27 induced by these conditions is accompanied by reciprocal changes in the expression levels of CD70, suggesting that these accessory molecules may be engaged in reciprocal receptor-ligand downmodulation. Consistent with this, we observe that co-culture of CLL B cells with transfected murine plasmacytoma cells that express human CD70 affects downmodulation of CD27 and enhanced expression of CD70 on leukemic B cells, but does not affect expression of CD27 mRNA. However, we find that CD40-crosslinking, in addition to reducing the level of CD27 protein, also reduces leukemic B-cell expression of CD27 mRNA. This argues that the changes in the expression levels of CD27 following CD40-signaling are not simply due to induced increases in the expression levels of CD70. Finally, we demonstrate that reciprocal changes in expression of CD27 and CD70 may contribute to the enhanced antigen-presenting capacity of CLL B cells after CD40-dependent leukemic B-cell activation. These findings expand the understanding of the regulation of costimulatory molecules important in antigen presentation and also have implications for the immunobiology of and therapy for CLL. 相似文献
66.
High-dose etoposide and cyclophosphamide without bone marrow transplantation for resistant hematologic malignancy 总被引:2,自引:1,他引:2
Brown RA; Herzig RH; Wolff SN; Frei-Lahr D; Pineiro L; Bolwell BJ; Lowder JN; Harden EA; Hande KR; Herzig GP 《Blood》1990,76(3):473-479
Seventy-five patients with resistant acute leukemia or lymphoma received high-dose cyclophosphamide and etoposide to explore the activity of this combination in resistant hematologic malignancies, and to determine the maximum doses of these drugs that can be combined without bone marrow transplantation. Etoposide was administered over 29 to 69 hours by continuous infusion corresponding to total doses of 1.8 g/m2 to 4.8 g/m2. Cyclophosphamide, 50 mg/kg/d, was administered on 3 or 4 consecutive days total 150 to 200 mg/kg ideal body weight). At all dose levels myelosuppression was severe but reversible. Mucosal toxicity was dose-limiting with the maximum tolerated dose level combining etoposide 4.2 g/m2 with cyclophosphamide 200 mg/kg. Continuous etoposide infusion produced stable plasma levels that were lower than would be achieved after administration by short intravenous infusion, and this could explain our ability to escalate etoposide above the previously reported maximum tolerated dose. There were 28 complete (35%) and 12 partial (16%) responses. Median duration of complete response (CR) was 3.5 months (range 1.1 to 20+). Seventeen of 40 patients (42%) with acute myelogenous leukemia (AML) achieved CR, including 6 of 20 (30%) with high-dose cytosine arabinoside resistance. We conclude that bone marrow transplantation is not required after maximum tolerated doses of etoposide and cyclophosphamide. This regimen is active in resistant hematologic neoplasms, and the occurrence of CR in patients with high-dose cytosine arabinoside-resistant AML indicates a lack of complete cross-resistance between these regimens. 相似文献
67.
Juan C. Diaz MD Jorge Romero MD Roberto Costa MD Alejandro Cuesta MD Luigi D. Biase MD Isabella Alviz MD Alejandro Velasco MD Mohamed Gabr MD Mauricio Duque MD Jorge E. Marin MD Julian Aristizabal MD Jorge Velasquez Cesar D. Niño MD Hector Mazzetti MD 《Journal of cardiovascular electrophysiology》2021,32(10):2715-2721
68.
69.
Macías Batista A Martínez Martín FJ de Pablos Velasco PL 《Anales de medicina interna (Madrid, Spain : 1984)》1999,16(2):87-88
A fourteen-year male patient presented a retrochiasmatic craniopharyngioma. Aer transcranial surgical resection, the patient had diabetes insipidus, which presented an interphase with manifestations of inadequate secretion of ADH. The patient was adequately treated with intranasal desmopresin, but aer i.v. fluid replacement was withdrawn, severe dehydration occurred. This was attributed to loss of the thirst reflex, due to surgical lesion of the lamina terminalis, where the osmoreceptor neurons are located. This case underscores the complications with body fluids and osmolality which may occur after surgery of hypothalamic lesions; i.e. diabetes insipidus (which may have a triphasic course), and adipsia, an infrequent complication due to absence of thirst. 相似文献
70.
Cerveró C Escribano L San Miguel JF Díaz-Agustín B Bravo P Villarrubia J García-Sanz R Velasco JL Herrera P Vargas M González M Navarro JL Orfao A 《American journal of hematology》1999,60(3):191-195
Bcl-2 protein plays a major role in the prevention of programmed cell death of differentiating cells. In the present study, the expression of cytoplasmic bcl-2 by human Bone Marrow Mast Cells (BMMC) from both normal and pathological bone marrow samples was examined. A total of 35 subjects corresponding to 9 healthy volunteers, 8 cases of adult indolent systemic mast cell disease (SMCD), 4 cases of pediatric mastocytosis (PM), 11 cases of hematological malignancies (HM), 2 cases of reactive bone marrow, and 1 case of mast cell leukemia (MCL) were analyzed. The expression of bcl-2 was studied using quantitative three-color flow cytometry. We also studied the molecular configuration of the bcl-2 gene and other relatives by Southern blot and polymerase chain reaction (PCR) in the MCL case. Bcl-2 expression was detected in BMMC from all samples analyzed. No significant differences on the expression of bcl-2 were detected between BMMC from healthy subjects and patients with SMCD, PM, HM, and reactive bone marrow. By contrast, bcl-2 protein was overexpressed in BMMC from MCL patient without gene rearrangement. Our results show that bcl-2 protein was constitutively expressed by BMMC. BMMC from MCL display overexpression of bcl-2, which could not be related to molecular rearrangements involving the bcl-2 gene. The expression of this protein by mature MC may play a role in the prevention of MC apoptosis and thus help to explain the long survival of these cells. The overexpression of bcl-2 by BMMC in MCL may help to explain their resistance to chemotherapy-induced apoptosis. 相似文献